Author:
Feliu J, ,Salud A,Escudero P,Lopez-Gómez L,Bolaños M,Galán A,Vicent J-M,Yubero A,Losa F,De Castro J,de Mon M Á,Casado E,González-Barón M
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Aparicio T, Desrame J, Lecomte T, Mitry E, Belloc J, Eitenney I, Montembault S, Vayre L, Locher C, Ezenfis J, Artru P, Mabro M, Dominguez S (2003) Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly. Br J Cancer 89: 1439–1444
2. Arkenau H, Schmoll H, Kublicka S, Kretzschmar A, Freier W, Seufferlein T, Graeven U, Grothey A, Hinke A, Porschen R (2005) Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) vs capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): results of the safety and efficacy analaysis. Proc Am Soc Clin Oncol 23: 247 (abstr. 3507)
3. Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5: 224–237
4. Baretta M, Bounadon M, Rupolo M, Frustaci S, Bearz A, Sorio R, Freschi A, Scalone S, Michieli M, Spina M, Tirelli U, Colussi AM, Cartei G (2001) Comparison between elderly and non-elderly patients (pts) of efficacy and tolerability of FOLFOX2 schedule in advanced colorectal cancer (col). Proc Am Soc Clin Oncol 20: 111 (abstr. 2195)
5. Blum JL, Jones SE, Buzdar AU, Lorusso PM, Kuter I, Vogel C, Osterwalder B, Burger HU, Brown CS, Griffin T (1999) Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17: 485–493
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献